Bluejay Diagnostics, Inc.
BJDX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001704287
In the last 90 days, Bluejay Diagnostics, Inc. insiders filed 1 open-market purchase and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $259.3K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Bluejay Diagnostics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 8 | 12 | +4 |
| Shares | 87.5K | 243.5K | +156.0K (+178.3%) |
| Value | $98.0K | $258.0K | +$160.0K (+163.3%) |
New holders (8)
Institutions that held Bluejay Diagnostics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 50,501 | $54.0K | 0.00% |
| Virtu Financial LLC | 42,912 | $45.0K | 0.00% |
| Sabby Management, LLC | 32,895 | $35.0K | 0.06% |
| Citadel Advisors LLC | 30,466 | $32.0K | 0.00% |
| Millennium Management LLC | 25,575 | $27.0K | 0.00% |
| Two Sigma Securities, LLC | 21,242 | $23.0K | 0.00% |
| Geode Capital Management, LLC | 12,420 | $13.0K | 0.00% |
| Northern Trust Corp | 11,699 | $12.0K | 0.00% |
Sold out (4)
Institutions that held Bluejay Diagnostics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Perkins Capital Management Inc | 22,500 | $25.0K |
| BlackRock Inc. | 20,835 | $23.0K |
| Jane Street Group, LLC | 15,913 | $18.0K |
| Tower Research Capital LLC (TRC) | 7,119 | $8.00K |